Literature DB >> 3171183

Effect of endogenous and synthetic sex steroids on the clearance of antibody-coated cells.

A D Schreiber1, F M Nettl, M C Sanders, M King, P Szabolcs, D Friedman, F Gomez.   

Abstract

Steroid hormones may influence the clinical expression of immunologic disease; however, their mechanism of action is uncertain. By using an experimental model, we studied the effect of sex steroids on the clearance of antibody-coated cells by macrophages in the spleen and liver. Progesterone significantly inhibited the clearance of IgG-coated E by splenic macrophages, whereas no effect was observed on the clearance of heat-altered E. This effect of progesterone was observed at serum concentrations which are attained during human pregnancy and the menstrual cycle. Furthermore, when splenic macrophages were isolated from progesterone-treated animals, they expressed decreased Fc gamma R activity. In addition, structural analogs of progesterone which have diminished glucocorticoid and progesterone activity retained this effect on macrophage Fc gamma R. In contrast, the estrogens estradiol and estriol as well as a structural estrogen analog with minimal estrogenic activity, 1,3,5(10)-estratrien-3,16 beta-diol, enhanced splenic macrophage Fc gamma R-dependent clearance. This action of estradiol could be partially inhibited by the antiestrogen tamoxifen. However, estradiol did not affect the C3-dependent clearance of IgM-coated E by hepatic macrophages. Concurrent administration of estradiol and progesterone demonstrated that the action of estradiol was predominant. These studies indicate that sex steroids alter splenic macrophage Fc gamma R function in vivo. This result may explain the alteration of disease activity in some human immunologic disorders during changes in hormonal state. Furthermore, analogs of progesterone and estrogen, as well as antiestrogens, which minimally affect the sex organs, retain the ability to alter splenic macrophage Fc gamma R function.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3171183

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

1.  Treatment with megestrol acetate improves human immunodeficiency virus-associated immune thrombocytopenia.

Authors:  Francisco Gomez; Pedro Ruiz; Rafaela Lopez; Consuelo Rivera
Journal:  Clin Diagn Lab Immunol       Date:  2002-05

Review 2.  Progesterone and autoimmune disease.

Authors:  Grant C Hughes
Journal:  Autoimmun Rev       Date:  2011-12-13       Impact factor: 9.754

3.  Enhancement of splenic-macrophage Fcgamma receptor expression by treatment with estrogens.

Authors:  F Gomez; P Ruiz; J A Bernal; M Escobar; A Garcia-Egido; J J Lopez-Saez
Journal:  Clin Diagn Lab Immunol       Date:  2001-07

4.  Effects of androgen treatment on expression of macrophage Fcgamma receptors.

Authors:  F Gomez; P Ruiz; R Lopez; C Rivera; S Romero; J A Bernal
Journal:  Clin Diagn Lab Immunol       Date:  2000-07

Review 5.  In vivo clearance by the mononuclear phagocyte system in humans: an overview of methods and their interpretation.

Authors:  C Halma; M R Daha; L A van Es
Journal:  Clin Exp Immunol       Date:  1992-07       Impact factor: 4.330

Review 6.  Diseases and drug-related interventions affecting host defence.

Authors:  S de Marie
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993       Impact factor: 3.267

7.  In vivo glucocorticoid modulation of guinea pig splenic macrophage Fc gamma receptors.

Authors:  P Ruiz; F Gomez; M King; R Lopez; C Darby; A D Schreiber
Journal:  J Clin Invest       Date:  1991-07       Impact factor: 14.808

Review 8.  Understanding Inter-Individual Variability in Monoclonal Antibody Disposition.

Authors:  Veena A Thomas; Joseph P Balthasar
Journal:  Antibodies (Basel)       Date:  2019-12-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.